Paul Tudor Jones's ADPT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 686,393 shares of Adaptive Biotechnologies Corporation (ADPT) worth $10.27 M, representing 0.02% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in ADPT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 452,252 shares. Largest reduction occurred in Q1 2024, reducing 71,205 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Adaptive Biotechnologies Corporation (ADPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adaptive Biotechnologies Corporation (ADPT) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2019 | +5,000 | New Buy | 5,000 | $48.40 |
| Q3 2019 | -5,000 | Sold Out | 5,000 | $0.00 |
| Q1 2021 | +6,591 | New Buy | 6,591 | $40.21 |
| Q2 2021 | +29,952 | Add 454.44% | 36,543 | $40.86 |
| Q3 2021 | -29,221 | Reduce 79.96% | 7,322 | $34.01 |
| Q4 2021 | +37,732 | Add 515.32% | 45,054 | $28.06 |
| Q1 2022 | -45,054 | Sold Out | 45,054 | $0.00 |
| Q3 2022 | +134,337 | New Buy | 134,337 | $7.12 |
| Q4 2022 | -134,337 | Sold Out | 134,337 | $0.00 |
| Q1 2024 | +63,132 | New Buy | 63,132 | $3.21 |
| Q2 2024 | +452,252 | Add 716.36% | 515,384 | $3.62 |
| Q3 2024 | +388 | Add 0.08% | 515,772 | $5.12 |
| Q4 2024 | -57,284 | Reduce 11.11% | 458,488 | $6.00 |
| Q1 2025 | +55,676 | Add 12.14% | 514,164 | $7.43 |
| Q2 2025 | +172,403 | Add 33.53% | 686,567 | $11.65 |
| Q3 2025 | -174 | Reduce 0.03% | 686,393 | $14.96 |
Paul Tudor Jones's Adaptive Biotechnologies Corporation Investment FAQs
Paul Tudor Jones first purchased Adaptive Biotechnologies Corporation (ADPT) in Q2 2019, acquiring 5,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Adaptive Biotechnologies Corporation (ADPT) for 26 quarters since Q2 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Adaptive Biotechnologies Corporation (ADPT) was in Q2 2024, adding 515,384 shares worth $1.87 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 686,393 shares of Adaptive Biotechnologies Corporation (ADPT), valued at approximately $10.27 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Adaptive Biotechnologies Corporation (ADPT) represents approximately 0.02% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Adaptive Biotechnologies Corporation (ADPT) was 686,567 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.